US Broker Ratings

Metsera, Inc. (MTSR) Stock Analysis: A 54.66% Upside in the Biotech Arena

Metsera, Inc. (MTSR), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its ambitious focus on tackling obesity and related diseases through innovative injectable and..

Edgewise Therapeutics, Inc. (EWTX) Investor Outlook: Exploring a 155% Potential Upside in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a trailblazer in the biotechnology sector, has been capturing the attention of investors with its focus on developing treatments for muscle disorders. With a market..

Integra LifeSciences Holdings (IART): Navigating Opportunities with a 16% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART) presents a fascinating mix of opportunities and challenges for investors in the healthcare sector. As a key player in the medical devices industry, Integra’s..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Balancing Act with a 19.59% Upside Potential

Pacira BioSciences, Inc. (NASDAQ: PCRX) presents a compelling case for investors who are attuned to the dynamics of the healthcare sector, particularly within the realm of innovative non-opioid pain management..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring a 125% Potential Upside Amidst Biotech Innovations

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage company focused on developing novel therapeutics for rare endocrine diseases, offers a compelling investment proposition with a remarkable potential upside of 125.11%. Despite..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Exploring Growth Potential with Innovative Biopharmaceuticals

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) is carving a niche in the biopharmaceutical landscape with its focus on developing and commercializing treatments for rare diseases and cancer. With a market capitalization..

MannKind Corporation (MNKD) Stock Analysis: Uncovering a 135% Potential Upside in Biotech Innovations

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, is catching the attention of investors with a compelling growth narrative and a significant potential upside. The company, based..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Navigating Growth in the Healthcare Sector

Healthcare Services Group, Inc. (NASDAQ: HCSG), a company with a market capitalization of $1.07 billion, occupies a significant position within the healthcare sector, specifically in the medical care facilities industry...

Select Medical Holdings Corp (SEM) Stock Analysis: A 32% Upside and Strong Buy Ratings Signal Growth Potential

Select Medical Holdings Corporation (NYSE: SEM) stands out in the healthcare sector with a promising growth trajectory that appeals to investors seeking opportunities in medical care facilities. With a market..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: 34.89% Potential Upside Captures Investor Attention

For investors eyeing opportunities in the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) offers a compelling proposition. With a market capitalization of $1.19 billion, this Houston-based company stands out..

Opko Health, Inc. (OPK) Stock Analysis: A Healthcare Play with 189% Potential Upside

Opko Health, Inc. (NASDAQ: OPK) stands out in the healthcare sector with its diversified operations in diagnostics and pharmaceuticals. Despite facing challenges with revenue growth and profitability, the stock presents..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 29.90% Potential Upside in the Dynamic Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS), a pioneering force in the healthcare industry, has been capturing the attention of investors with its innovative approach to cardiovascular care. Based in Kirkland, Washington,..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 63% Potential Upside for Investors

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector’s diagnostics and research industry, presents a compelling opportunity for investors eyeing substantial potential upside. With a market capitalization of..

Artivion, Inc. (AORT) Stock Analysis: Navigating Potential Upside in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT), a prominent player in the medical devices industry, is catching the eye of investors with its potential upside of 10.77%, as indicated by recent analyst ratings...

Amphastar Pharmaceuticals (AMPH) Stock Analysis: Exploring a 21.71% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector, specializes in the development and distribution of both generic and proprietary injectable, inhalation, and intranasal products. With a..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a 21.32% Potential Upside for Investors

Pediatrix Medical Group, Inc. (NASDAQ: MD), a prominent player in the healthcare sector, is turning heads with a compelling potential upside of 21.32%, according to the latest analyst ratings. With..

Ligand Pharmaceuticals (LGND) Stock Analysis: Unveiling a 31% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is capturing significant attention in the biotechnology sector, driven by its robust pipeline and promising market positioning. With a market capitalization of $2.11 billion, Ligand..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating a 28% Potential Upside for Investors

Investors seeking opportunities in the healthcare sector may find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing option. Despite its current challenges, the company presents a notable 28.08% potential upside based..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Navigating the Future of Bioelectric Medicine with an Eye on Growth Potential

Pulse Biosciences, Inc. (NASDAQ: PLSE), a formidable player in the healthcare sector, is making waves in the medical instruments and supplies industry with its pioneering bioelectric medicine technologies. Headquartered in..

89bio, Inc. (ETNB) Stock Analysis: Exploring a Potential 178% Upside in the Biotech Market

89bio, Inc. (NASDAQ: ETNB), a promising player in the biotechnology sector, has caught the attention of investors with its ambitious approach to addressing liver and cardio-metabolic diseases. Specializing in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds